350633 <common-name>3-[2-[4-(4-methylphenyl)piperazin-1-yl]-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one</common-name> <description>3-[2-[4-(4-methylphenyl)piperazin-1-yl]-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one is a chemical compound with the formula C30H32N4O5. With an average molecular weight of 528.60 g/mol, 3-[2-[4-(4-methylphenyl)piperazin-1-yl]-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one is a heavy molecule.</description> <cas>83409-16-9</cas> <pubchem-id>3068412</pubchem-id> <chemical-formula>C30H32N4O5</chemical-formula> <weight>528.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:49:15Z</created-at> <updated-at type="dateTime">2026-08-31T15:49:15Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=C(C=C1)N2CCN(CC2)C(=O)CN3C(=NC4=CC=CC=C4C3=O)C5=CC(=C(C(=C5)OC)OC)OC</moldb-smiles> <moldb-formula>C30H32N4O5</moldb-formula> <moldb-inchi>InChI=1S/C30H32N4O5/c1-20-9-11-22(12-10-20)32-13-15-33(16-14-32)27(35)19-34-29(31-24-8-6-5-7-23(24)30(34)36)21-17-25(37-2)28(39-4)26(18-21)38-3/h5-12,17-18H,13-16,19H2,1-4H3</moldb-inchi> <moldb-inchikey>MEVUIBAKPBKDOF-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">528.2372701</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346526</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-[2-[4-(4-methylphenyl)piperazin-1-yl]-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Diazinanes</klass> <subklass>Piperazines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300938</sync-id> <structure-inchikey>MEVUIBAKPBKDOF-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>80000010000100000000000000000000000000500040000000204000002000040010000000200400010000000000000000000000008000000000000000000000000000000000002000000001010000000000000000800000000021000000004400000010000100000002010000000000000000004000000000004000000080400000000000000080000000010000000000000000000000000000c000000000040000080000060000000002000000008000000800000080000000040004010000000000000000000000008000002000000200000000000000000140000001000040000800000480000000000020000000004000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKwAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB BwAoAAAAAwMGAGAAAAACAgYAYAAAAAICBwAoAAAAAwMGAGAAAAACAgYAYAAA AAICBgAoAAAAAwQIACgAAAADAgYAYAAAAAICB0AoAAAAAwMGQCgAAAADBAdA KAAAAAMDBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgA AAADAwEGQCgAAAADBAZAKAAAAAMECAAoAAAAAwIGQCgAAAADBAZAaAAAAAMD AQZAKAAAAAMEBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQgAKAAAAAMCBgBg AAAAAQMIACgAAAADAgYAYAAAAAEDCAAoAAAAAwIGAGAAAAABAwsAAQABAmgM AgNoDAMEaAwEBWgMBQZoDAQHIAcIAAgJAAkKAAoLAAsMAAoNIA0OKAINDwAP EAAQEWgMERJoDBITaAwTFGgMFBVoDBUWaAwWF2gMFxhoDBgZaAwZGigCERsg GxxoDBwdaAwdHmgMHh9oDB8gaAwfISAhIgAeIyAjJAAdJSAlJgAGAWgMDAcA GRBoDBgTaAwgG2gMQgUAAAAGAQYFBAMCBggJCgsMBwYSExgZEBEGFBUWFxgT BhwdHh8gGxcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:38Z</structure-indexed-at> </compound>